NRGBiotic [Pilot 2]

CLINICAL TRIAL

A Phase I safety and exploratory end-point trial investigating the role of Probiotics and Magnesium Orotate [NRGBiotic] co-administered with Antidepressant Medications for the Management of Treatment Resistant Depression

NEAF initiated online on

-

DATE of HREC approval

Extension of HREC approved study

HREC Reference number

UQHREC | 2012000647

CTN application submitted to TGA on

-

CTN

-

ANZCTR date submitted | date registered

-

ANZCTR

-

STATUS

Recruiting Closed